You are here

  • Home
  • Archive
  • Volume 70, Issue 10
  • Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Article info

Article menu
Download PDFPDF
Review
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Authors

  1. Correspondence to Professor Pierre Miossec, Department of Clinical Immunology and Rheumatology, Hospital Edouard Herriot, 69437 Lyon Cedex 03, France; pierre.miossec{at}univ-lyon1.fr
View Full Text

Citation

Miossec P, Verweij CL, Klareskog L on behalf of the Group for the Respect of Ethics and Excellence in Science (GREES), et al
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies
Annals of the Rheumatic Diseases 2011;70:1713-1718.

Publication history

  • Accepted June 11, 2011
  • First published July 22, 2011.
Online issue publication 
September 05, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions